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Abstract
Generally, adenocarcinomas with micropapillary pattern, featuring small papillary tufts lacking a central fibrovascular
core, are thought to have poor prognosis. This pattern has been described in various organs. However, tumor cells
with micropapillary pattern of lung adenocarcinoma are more often seen to float within alveolar spaces
(aerogenous micropapillary pattern, AMP) than in fibrotic stroma like other organs (stromal micropapillary pattern,
SMP) and SMP predominant lung adenocarcinoma (SMPPLA) has not been well described yet. We presented two
cases of SMPPLA which were found in the last four years. Both the cases showed more than 50% of SMP in the
tumor area. The majority of the stromal micropapillary clusters expressed MUC1 and epithelial membrane antigen
along the outer surface of cell membrane. On the other hand, connective tissues surrounding stromal
micropapillary clusters showed no reactivity for epithelial markers (thyroid transcription factor-1 and cytokeratin) or
endothelial marker (D2-40 and CD34). It means clusters of SMP do not exist within air space or lymphatic or vessel
lumens. The tumors with SMP often presented lymphatic permeation and vessel invasion, and intriguingly, one of
the two cases showed metastasis to the mediastinal lymph node. Additionally, both the cases showed EGFR point
mutations of exon 21. These results suggest that SMPPLA might be associated with poor prognosis and effective
for EGFR tyrosine kinase inhibitors.
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Background
A new lung adenocarcinoma classification has been pro-
posed by the International Association for the Study of
Lung Cancer, American Thoracic Society and European
Respiratory Society (IASLC/ATS/ERS). In this classifica-
tion, the micropapillary subtype of lung adenocarcinoma
(MSLA) was recommended as a newly added subtype of
lung adenocarcinoma to lepidic, acinar, papillary, and solid
subtypes defined in the 2004 World Health Organization
(WHO) classification [1,2]. Generally, the micropapillary
pattern is defined as tumor cells growing in papillary tufts,
which lack fibrovascular cores surrounded by lacunar
spaces and has been reported to be associated with a high
incidence of nodal metastasis and poor prognosis [3-6].
This pattern has been described in various organs such as
breast [7,8], urinary bladder [9,10], ovary [11,12], salivary
gland [13], and is known to behave aggressively. In other
organs than the lung, this pattern was observed mainly in
stroma as invasive components (stromal micropapillary
pattern: SMP) [7-19]; however in lung, MSLA is widely
recognized as floating tumor cells within alveolar spaces
(aerogenous micropapillary pattern: AMP) [3,4].
We examined whether SMP predominant subtypes
were present in lung adenocarcinoma. During the period
from February 2007 to December 2010, 559 patients
with lung adenocarcinoma were consecutively treated by
surgical resection at the Kanagawa Cancer Center,
Kanagawa, Japan, and we found only two cases of SMP
predominant lung adenocarcinoma (SMPPLA) (0.36%).
We reported the cases of SMPPLA and attempted to
describe the clinicopathological features.
* Correspondence: ohem@kcch.jp
1Department of Pathology, Kanagawa Cancer Center, Kanagawa, Japan
Full list of author information is available at the end of the article
Ohe et al. Diagnostic Pathology 2011, 6:92
http://www.diagnosticpathology.org/content/6/1/92
© 2011 Ohe et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Case presentation
Clinical summary
Case1
A 49-year-old Japanese man was referred to the hospital
with lung adenocarcinoma, which was diagnosed by the
transthoracic needle biopsy. A computed tomography
(CT) scan detected a 32 mm-sized localized solid tumor
in the right upper lobe and swelling of the mediastinal
lymph node (Figure 1a). He was an ex-smoker and
admission laboratory tests showed increased carcinoem-
bryonic antigen (9.6 ng/mL). A right upper lobectomy
with lymph node dissection was performed and the
tumor was diagnosed as lung adenocarcinoma in patho-
logical T2aN2M0 and stage IIIA determined on the
basis of the TNM classification of Union of Interna-
tional Cancer Control [20]. After that, he underwent
postoperative adjuvant chemotherapy, and he was alive
without recurrence ten months after operation.
Case2
A 57-year-old Japanese man who was a never smoker was
referred to the hospital with abnormal shadow on his
chest CT scan. A CT scan detected a 29 mm-sized loca-
lized solid nodule with pleural indentation in the right
upper lobe, and the histological diagnosis of the tumor
by transbronchoscopic biopsy was lung adenocarcinoma
(Figure 1b). Laboratory tests showed slightly elevated
squamous cell carcinoma antigen (1.6 ng/mL). A right
upper lobectomy with lymph node dissection was per-
formed and diagnosed lung adenocarcinoma in patholo-
gical T2aN0M0 and stage IB. After that, he underwent
postoperative adjuvant chemotherapy, and he was alive
without recurrence nine months after operation.
Pathological findings
The excised specimens were fixed in a solution of 10%
buffered formaldehyde and the sections were embedded
in paraffin. Four micrometer-thick sections including the
largest cut surface of the tumor were prepared and
stained with hematoxylin and eosin (HE), alcian blue and
elastica-van-Gieson (AB-EVG) stain. Immunohistochem-
ical staining was performed with the primary antibodies
listed in Table 1. Lepidic, acinar, papillary and solid sub-
types of lung adenocarcinoma were determined accord-
ing to the 2004 WHO classification. AMP of lung
adenocarcinoma was determined according to the
IASLC/ATS/ERS international multidisciplinary classifi-
cation of lung adenocarcinoma [1].
Macroscopic examination of the excised specimens
showed the sharply-demarcated tumor measuring 36 ×
25 × 30 mm in size, white in color on cut surface in the
case 1 (Figure 2a), and the tumor measuring 33 × 20 ×
40 mm in size, grayish white in color on cut surface in
the case 2 (Figure 2b).
Microscopically, the tumors of both the cases were
composed of stromal micropapillary predominant adeno-
carcinoma, which were proliferation of nonmucinous aty-
pical cuboidal epithelial cells. In the case 1, the tumor
was composed of 55% SMP, 5% lepidic, 30% acinar, 5%
papillary pattern and 5% AMP (Figure 3a). In the case 2,
the tumor was composed of 55% SMP, 20% lepidic and
25% acinar pattern (Figure 3b) and lacked AMP. In both
the cases, lymphatic and vessel invasion were often
observed. Lymphatic invasion was confirmed on immu-
nohistochemistry using D2-40 antibody. The case 1
showed pleural invasion and resected regional lymph
nodes had metastatic foci composed of tumor cells with a
micropapillary pattern (Figure 4).
Immunohistochemically, the outer surface of the SMP
cell clusters in both the cases showed membranous
expression of MUC1 and epithelial membrane antigen
(EMA), indicating an ‘inside-out’ pattern. Both the cases
showed E-cadherin expression on intercellular cell mem-
branes of micropapillary tufts of SMP tumor cells.
Tumor cells constituting SMP showed positive staining
for Ki-67 (MIB-1, Dako, Glostrup, Denmark); positive
Figure 1 Enhanced chest CT of the lung.C h e s tC To fc a s e1( a )
and case 2 (b) showed a tumor of the right upper lobe of the lung.
(a) Chest CT revealed a tumor with pleural indentation, without
ground glass opacity (GGO). The tumor was 32 mm in diameter and
mildly enhanced. (b) Chest CT revealed a nodule with GGO, pleural
indentation, air bronchogram and venous involvement. The nodule
was 29 mm in diameter and mildly enhanced.
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nent, positive and negative tumor cells for thyroid tran-
scription factor-1 (TTF-1) and surfactant protein A (SP-
A) staining were observed in the case 1, on the other
hand, the case 2 showed TTF-1 expression and SP-A
repression in almost all tumor cells. Tumor cells outside
SMP showed MUC1 and EMA expression on free surface
of cell membrane, but MUC1 positive cells were fewer
than those in SMP. Tumor cells outside SMP in case 1
showed strong TTF-1 expression. D2-40, CD34 and fac-
tor VIII were not found in cells constituting micropapil-
lary tufts. Moreover TTF-1, cytokeratin (CK), D2-40,
CD34 and factor VIII were negative in luminal inner sur-
face surrounding micropapillary tufts (Table 1 Figure 5a-
d). These results means micropapillary tufts of SMP lack
fibrovascular core and were not located within alveolar
space, vascular or lymphatic vessels.
Mutational analysis
A study of epidermal growth factor receptor (EGFR)
gene status of exon 19 and 21 was performed by the
methods described elsewhere [21]. Written informed
consent for genetic analysis of the tumor cells was
obtained from the patients. As a result, both the cases
showed an L858R point mutation at exon 21.
Discussion
In the two cases presented, we recognized that tumor
cells of SMP had reduced expression of SP-A, but tumor
cells outside SMP had its strong expression. Additionally,
we identified the tumor cluster cells were surrounded by
t h ec o n n e c t i v et i s s u ew h i c hw a sn e g a t i v ef o rT T F - 1o r
CK. And these components were also negative for D2-40
and CD34. The results suggested micropapillary tufts of
SMP were not located within alveolar space, vascular or
lymphatic vessels but in stroma and reduced the pheno-
typic expression like SP-A [22].
AMP of MSLA has been reported to express of MUC1
[6]. We identified expression of MUC1 and EMA in the
outer surface of papillary clusters like those in AMP of
the case 1. This staining pattern is called as an ‘inside-
out’ pattern in the invasive micropapillary carcinoma of
Table 1 Antibodies used and immunohistchemical result
Antibody Clone Dilution Source Stroma around the micropapillary clusters Tumor cells
in SMP outside SMP
Case1 Case2 Case1 Case2 Case1 Case2
MUC1 Ma695 1:100 Novocastra 0 0 2+ 2+ 1+ 2+
EMA E29 Pre-diluted Cell Marque 0 0 2+ 2+ 2+ 2+
E-cadherin NCH38D 1:100 DakoCytomation 0 0 2+ 2+ 2+ 2+
CK AE1/AE3 Pre-diluted Nichirei 0 0 2+ 2+ 2+ 2+
TTF-1 8G7G3/1 1:100 DakoCytomation 0 0 1+ 2+ 2+ 2+
SP-A PE10 1:100 Dako 0 0 1+ 0 2+ 2+
D2-40 D2-40 Pre-diluted Nichirei 0 0 0000
CD34 Nu-4A1 Pre-diluted Nichirei 0 0 0000
FactorVIII polyclonal 1:200 DAKO 0 0 0000
EMA, epithelial membrane antigen; CK, cytokeratin; TTF-1, thyroid transcription factor-1; SP-A, surfactant protein A.
Novocastra, Newcastle Upon Tyne, UK; Cell Marque, Hot springs, AR, USA; DakoCytomation, Carpinteria, CA, USA; Dako, Kyoto, Japan; Nichirei, Tokyo, Japan;
DAKO, Glostrup, Denmark.
0, no positive cells; 1+, positive tumor cells less than 10%; 2+, 10% or more.
Figure 2 Macroscopic findings. Macroscopic examination of
excised specimens showed the tumor measuring 36 × 25 × 30 mm
in size, white in color on cut surface in the case 1 (a), and the
tumor measuring 33 × 20 × 40 mm in size, grayish-white in color
on cut surface containing areas of hemorrhage in the case 2 (b).
White squares in Figure 2a and 2b correspond to photomicrographs
of Figure 3a and 3b, respectively.
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polarity called as an ‘inside-out’ pattern of the tumor
cells is thought to be a characteristic feature in SMP
and AMP of lung adenocarcinoma.
Previous studies have reported that a micropapillary
pattern is associated with a poor prognosis in stage I
lung adenocarcinoma because of its aggressive behavior,
as shown by frequent lymph node metastasis, lymphatic
permeation, vascular invasion and pleural invasion [4-6].
In the current two cases, lymphatic permeation and vas-
cular invasion were often observed. In addition, the case
1 showed pleural invasion and the resected regional
Figure 3 Photomicrographs. Stromal micropapillary pattern characterized by papillary structures with tufts lacking a central fibrovascular core
and surrounding clear spaces in fibrotic stroma was seen in both case 1 (a) and case 2 (b). (HE stains ×100; inset, ×400)
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Page 4 of 7Figure 4 Photomicrographs. (a) A resected regional lymph node had metastatic foci composed of tumor cells with a micropapillary pattern in
the case 1. (HE stain, ×200) (b) Vessel invasion by tumor cells in the case 1. (AB-EVG stain, ×100) (c, d) Tumor cells in lymphatic ducts, which
were covered by D2-40 positive endothelial cells. (c, ×200, case 1; d, ×400, case 2).
Figure 5 Immunohistochemical photomicrographs of case 1. (a) Tumor clusters of stromal micropapillary pattern had MUC1 expression on
the outer surface strongly, indicating ‘inside-out’ pattern. (×200) (b) D2-40 and (c) CD34 were not found in cells consisting micropapillary tufts
and (d) CK was not found in connective tissue surrounding the tumor cells. (b, c, ×200; d, ×400).
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cells with a micropapillary pattern. Though it is too
early to refer to prognosis of SMPPLA because of short
duration of observation, we may say SMPPLA has
strong association with vascular invasion.
We also performed a mutational analysis of EGFR
gene mutations and both the cases showed EGFR muta-
tions of exon 21. These results suggest that SMPPLA
might be associated with poor prognosis and effective
for EGFR tyrosine kinase inhibitors.
In conclusion, we recognized the presence of
SMPPLA. Since SMPPLA is very rare as far as we inves-
tigated, further studies are required to determine the
clinical significance of SMPPLA in detail.
Consent
Written informed consent was obtained from the patients
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
Abbreviations
AMP: aerogenous micropapillary pattern; SMP: stromal micropapillary pattern;
SMPPLA: SMP predominant lung adenocarcinoma; MSLA: the micropapillary
subtype of lung adenocarcinoma
Acknowledgements
The authors thank the technicians of the Pathology Laboratory Division in
the hospital for the technical assistance.
Author details
1Department of Pathology, Kanagawa Cancer Center, Kanagawa, Japan.
2Department of Thoracic Oncology, Kanagawa Cancer Center, Kanagawa,
Japan.
3Molecular Pathology and Genetics Division, Kanagawa Cancer Center
Research Institute, Kanagawa, Japan.
4Division of Clinical Oncology and
Respiratory Medicine, Department of Internal Medicine, Shimane University
Faculty of Medicine, Shimane, Japan.
Authors’ contributions
MO and TY designed the study, performed clinical and pathological
investigation, and wrote the drafts. YS participated in pathological and
genetical investigation. SO performed the histological and
immunohistochemical evaluation. CH, KW, KN, TW and RH assisted the
clinical investigation. HN participated in managing and operating the
patients. YK assisted the pathological investigation. KY participated in
collecting clinical data and images. TI participated in its design and
coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 July 2011 Accepted: 29 September 2011
Published: 29 September 2011
References
1. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y,
Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H,
Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J,
Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J,
Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, et al: International
Association for the Study of Lung Cancer/American Thoracic Society/
European Respiratory Society international multidisciplinary classification
of lung adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
2. Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MK, Park BJ,
Rusch VW, Travis WD: Impact of proposed IASLC/ATS/ERS classification of
lung adenocarcinoma: prognostic subgroups and implications for further
revision of staging based on analysis of 514 stage I cases. Mod Pathol
2011, 24:653-664.
3. Amin MB, Tamboli P, Merchant SH, Ordóñez NG, Ro J, Ayala AG, Ro JY:
Micropapillary component in lung adenocarcinoma: a distinctive
histologic feature with possible prognostic significance. Am J Surg Pathol
2002, 26:358-364.
4. Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E,
Ishikawa Y: Early-stage lung adenocarcinoma with micropapillary pattern,
a distinct pathologic marker for a significantly poor prognosis. Am J Surg
Pathol 2003, 27:101-109.
5. Nagano T, Ishii G, Nagai K, Ito T, Kawase A, Takahashi K, Nishimura Y,
Noshiwaki Y, Ochiai A: Structural and biological properties of a papillary
component generating a micropapillary component in lung
adenocarcinoma. Lung Cancer 2010, 67:282-289.
6. Tsutsumida H, Nomoto M, Goto M, Kitajima S, Kubota I, Hirotsu Y,
Wakimoto J, Hollingsworth MA, Yonezawa S: A micropapillary pattern is
predictive of a poor prognosis in lung adenocarcinoma, and reduced
surfactant apoprotein A expression in the micropapillary pattern is an
excellent indicator of a poor prognosis. Mod Pathol 2007, 20:638-647.
7. Kuba S, Ohtani H, Yamaguchi J, Hayashi H, Uga T, Kanematsu T,
Shimokawa I: Incomplete inside-out growth pattern in invasive breast
carcinoma: association with lymph vessel invasion and recurrence-free
survival. Virchows Arch 2011, 458:159-169.
8. Guo X, Chen L, Lang R, Fan Y, Zhang X, Fu : Invasive micropapillary
carcinoma of the breast: association of pathologic features with lymph
node metastasis. Am J Clin Pathol 2006, 126:740-746.
9. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA,
Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS,
Tamboli P, McKenney JK: Interobserver reproducibility in the diagnosis of
invasive micropapillary carcinoma of the urinary tract among urologic
pathologists. Am J Surg Pathol 2010, 34:1367-1376.
10. Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordóñez NG,
Ayala AG: Micropapillary variant of transitional cell carcinoma of the
urinary bladder. Histologic pattern resembling ovarian papillary serous
carcinoma. Am J Surg Pathol 1994, 18:1224-1232.
11. Burks RT, Sherman ME, Kurman RJ: Micropapillary serous carcinoma of the
ovary. A distinctive low-grade carcinoma related to serous borderline
tumors. Am J Surg Pathol 1996, 20:1319-1330.
12. Eichhorn JH, Bell DA, Young RH, Scully RE: Ovarian serous borderline
tumors with micropapillary and cribriform patterns: a study of 40 cases
and comparison with 44 cases without these patterns. Am J Surg Pathol
1999, 23:397-409.
13. Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M: Aggressive invasive
micropapillary salivary duct carcinoma of the parotid gland. Pathology Int
2008, 58:322-336.
14. Mogi A, Nabeshima K, Hamasaki M, Uesugi N, Tamura K, Iwasaki A,
Shirakusa T, Iwasaki H: Pleural malignant mesothelioma with invasive
micropapillary component and its association with pulmonary
metastasis. Pathology Int 2009, 59:874-879.
15. Kondo T: Bile duct adecarcinoma with minor micropapillary component:
a case report. Cases Journal 2009, 2:51.
16. Shimoda M, Okada Y, Hayashi Y, Hatano S, Kawakubo H, Omori T, Ishii S,
Sugiura H: Primary invasive micropapillary carcinoma of the stomach.
Pathology Int 2008, 58:513-517.
17. Sakamoto K, Watanabe M, Cruz CD, Honda H, Ise H, Mitsui K, Namiki K,
Mikami Y, Moriya T, Sasano H: Primary invasive micropapillary carcinoma
of the colon. Histopathology 2005, 47:479-484.
18. Verdú M, Roman R, Calvo M, Rondon N, Garcia B, Gonzalez M, Vidal A,
Puig X: Clinicopathological and molecular characterization of colorectal
micropapillary carcinoma. Mod Pathol 2011, 24:729-738.
19. Kim MJ, Hong SM, Jang SJ, Yu E, Kim JS, Kim KR, Gong G, Ro JY: Invasive
colorectal micropapillary carcinoma: an aggressive variant of
adenocarcinoma. Hum Pathol 2006, 37:809-815.
20. Sobin LH, Gospodarowicz MK, Wittekind C, editors: TNM classification of
malignant tumors, seventh edition. Wiley-Blackwell; 2009.
Ohe et al. Diagnostic Pathology 2011, 6:92
http://www.diagnosticpathology.org/content/6/1/92
Page 6 of 721. Matsukuma S, Yoshihara M, Kasai F, Kato A, Yoshida A, Akaike M,
Kobayashi O, Nakayama H, Sakuma Y, Yoshida T, Kameda Y, Ysuchiya E,
Miyagi Y: Rapid and simple detection of hot spot mutations of
epidermal growth factor receptor, BRAF, and NRAS in cancers using the
loop-hybrid mobility shift assay. J Mol Diagn 2006, 8:504-512.
22. Goldmann Torsten, Kähler Daniel, Schultz Holger, Abdullah Mahdi,
Lang SDagmar, Stellmacher Florian, Vollmer Ekkehard: On the significance
of Surfactant Protein-A within the human lungs. Diagnostic Pathology
2009, 4:8-12.
doi:10.1186/1746-1596-6-92
Cite this article as: Ohe et al.: Stromal micropapillary pattern
predominant lung adenocarcinoma - a report of two cases. Diagnostic
Pathology 2011 6:92.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Ohe et al. Diagnostic Pathology 2011, 6:92
http://www.diagnosticpathology.org/content/6/1/92
Page 7 of 7